Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections.
Michael A PfallerCecilia Godoy CarvalhaesSean DeVriesPaul Richard RhombergMariana CastanheiraPublished in: Medical mycology (2022)
Secondary infections were documented in COVID-19 patients. We compared the prevalence of invasive fungal isolates consecutively collected in 48 worldwide hospitals and their susceptibility patterns between 2020, the year of the global COVID-19 pandemic, and the two prior years.